Axatilimab for Treatment of Patients With Oral Chronic Graft-Versus-Host Disease: A Post Hoc Analysis of the AGAVE-201 Study. // Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. – URL: https://www.sciencedirect.com/science/article/pii/S2212440326005092?dgcid=rss_sd_all
Axatilimab for Treatment of Patients With Oral Chronic Graft-Versus-Host Disease: A Post Hoc Analysis of the AGAVE-201 Study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. https://www.sciencedirect.com/science/article/pii/S2212440326005092?dgcid=rss_sd_all
“Axatilimab for Treatment of Patients With Oral Chronic Graft-Versus-Host Disease: A Post Hoc Analysis of the AGAVE-201 Study.” Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.
@article{article29013,
title = {Axatilimab for Treatment of Patients With Oral Chronic Graft-Versus-Host Disease: A Post Hoc Analysis of the AGAVE-201 Study},
journal = {Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology},
url = {https://www.sciencedirect.com/science/article/pii/S2212440326005092?dgcid=rss_sd_all}
}